Unibio International has announced that the $4.8billion Saudi Industrial Investment Group “SIIG” has agreed to invest $70million, facilitating the rollout of Unibio’s microbial fermentation technology to meet global demand for high quality alternative protein, initially targeting the $450billion per annum animal feed market. 

The investment represents a substantial development in the West Hill portfolio, positioning Unibio on an exciting trajectory towards its vision of providing a solution to a growing protein deficit, feeding the global population in a sustainable way. The Company’s unique “U-Loop” technology mimics a process that naturally occurs in nature at an industrial scale, using methane to produce Uniprotein, a nutritious and high-quality animal feed product.

David Henstrom, CEO of Unibio commented: 

“We are delighted to welcome SIIG as a significant investor in Unibio. 

Their investment will enable us to play a pivotal role in meeting our customers’ need for sustainable protein. Unibio’s technology will improve food security and speed up the process of feeding the world in a sustainable way. 

We are pleased that SIIG shares our ambition of providing food security for the world’s growing population and helping stop hunger (#SDG2) and we look forward to working together to make it happen.” 

Mr. Abdulrahman S. Alismail, CEO of the Saudi Industrial Investment Group, added

“We are extremely pleased to invest in Unibio and see it as strongly aligned with SIIG’s new strategy to diversify its investments, enter new sectors focused on sustainability and new technologies, and develop partnerships with international companies. 

Unibio’s focus aligns with Saudi Arabia’s commitment to increasing domestic protein production and supporting food security through innovation and technology. 

We are investing in Unibio for the long-term and believe that by doing so we will contribute to a more diverse and sustainable economy.” 

West Hill has backed Unibio through multiple funding rounds over several years, including at seed stage, where West Hill investors have seen the value of their holding increase by more than 30x, whilst those that subscribed in the Company’s initial EIS round are up by more than 9x.  That said, this larger investment round is expected to be a catalyst for very substantial growth from here, leading to a dramatic increase in revenues and profits. Funds raised will be deployed in building three full scale industrial plants, potentially producing sales in the hundreds of millions in the coming years. 

Beyond that, significant global interest from major customers and partners is expected to lead to additional joint ventures and licensing agreements, expanding production capacity to meet soaring demand, potentially enabling Unibio to become a very substantial international business.